Related Experiment Video
Updated: Jan 9, 2026

Isolation of Intrapulmonary Artery and Smooth Muscle Cells to Investigate Vascular Responses
Published on: June 8, 2022
Rho-kinase-mediated regulation of receptor-agonist-stimulated smooth muscle contraction
1Institute of Basic Medical Sciences, National Cheng-Kung University College of Medicine, Tainan, Taiwan.
Abstract:
Rho kinase was shown to regulate smooth muscle contraction through modulating myosin phosphatase (MLCP) activity, but the in vivo mechanism remains to be clarified. This study examined the effects of Rho kinase inhibition on the phosphorylation time course of MLCP subunit MYPT1 at Thr697 and Thr855 and MLCP inhibitory protein CPI-17 at Thr38 and on actin polymerization during the contraction of rat tail artery (RTA) smooth muscle. Rho kinase inhibitor Y27632 suppressed force activated by alpha(1)-adrenergic agonist phenylephrine or thromboxane A(2) analog U46619 with concomitant decreases in MLC(20) phosphorylation. Phenylephrine and U46619 significantly increased MYPT1(Thr855) phosphorylation that was eliminated by Y27632 pretreatment, whereas MYPT1(Thr697) phosphorylation was not stimulated. Phenylephrine increased CPI-17(Thr38) phosphorylation that was not inhibited by Y27632 but was abolished by a protein kinase C inhibitor Ro 31-8220; in contrast, U46619 did not stimulate CPI-17 phosphorylation. Both agonists increased actin polymerization that was diminished by Y27632 under phenylephrine but not U46619 activation. These results demonstrated a temporal correlation between MYPT1(Thr855) phosphorylation, MLC(20) phosphorylation, and contraction in a Rho-kinase-dependent manner for both phenylephrine and U46619 stimulation, suggesting that Rho kinase regulates MLCP activity through MYPT1(Thr855) phosphorylation during RTA smooth muscle contraction. Furthermore, Rho kinase regulates actin polymerization activated by alpha(1)-adrenoceptors but is less significant in thromboxane receptor stimulation.
Insights
Rho kinase regulates smooth muscle contraction by phosphorylating MYPT1 at Thr855, impacting myosin phosphatase activity. This mechanism is crucial for force generation and actin polymerization in rat tail artery smooth muscle.
Area of Science:
- Physiology
- Biochemistry
- Pharmacology
Background:
- Rho kinase plays a role in smooth muscle contraction by modulating myosin phosphatase (MLCP) activity.
- The precise in vivo mechanism of Rho kinase in regulating MLCP activity requires further clarification.
Purpose of the Study:
- To investigate the in vivo effects of Rho kinase inhibition on MLCP subunit MYPT1 and CPI-17 phosphorylation.
- To examine the role of Rho kinase in actin polymerization during rat tail artery (RTA) smooth muscle contraction.
Main Methods:
- Used Rho kinase inhibitor Y27632 to study RTA smooth muscle contraction.
- Measured phosphorylation of MYPT1 (Thr697, Thr855) and CPI-17 (Thr38).
- Assessed actin polymerization and MLC(20) phosphorylation.
Main Results:
- Y27632 suppressed phenylephrine- and U46619-induced force and MLC(20) phosphorylation.
- Phenylephrine and U46619 increased MYPT1(Thr855) phosphorylation, abolished by Y27632.
- Rho kinase inhibition reduced actin polymerization under phenylephrine but not U46619 stimulation.
Conclusions:
- Rho kinase regulates MLCP activity via MYPT1(Thr855) phosphorylation during RTA smooth muscle contraction.
- Rho kinase is essential for alpha(1)-adrenoceptor-mediated actin polymerization, with a lesser role in thromboxane receptor stimulation.
Related Concept Videos
Nitric Oxide Signaling Pathway
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Amplifying Signals via Enzymatic Cascade
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Smooth Muscle Contraction
The onset of contraction is triggered by an increase in calcium ions within the sarcoplasm, similar to the process in striated muscle. However, smooth muscles have a relatively smaller reservoir of the sarcoplasmic...
Antihypertensive Drugs: Vasodilators

